Breakwater Capital Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Breakwater Capital Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.18M	Buy	20,157 +501	+3%	+$79.1K	0.38%	62
2026 Q2	$3.11M	Buy	19,656 +2,409	+14%	+$326K	0.37%	68
2026 Q1	$2.2M	Buy	17,247 +476	+3%	+$59.4K	0.3%	77
2025 Q4	$2.04M	Buy	16,771 +1,884	+13%	+$216K	0.29%	84
2025 Q3	$1.49M	Buy	14,887 +3,726	+33%	+$336K	0.22%	103
2025 Q2	$926K	Buy	11,161 +7,068	+173%	+$564K	0.15%	140
2025 Q1	$332K	Sell	4,093 -1,173	-22%	-$105K	0.06%	260
2024 Q4	$474K	Buy	5,266 +744	+16%	+$72.1K	0.09%	187
2024 Q3	$447K	Buy	4,522 +1,185	+36%	+$116K	0.09%	186
2024 Q2	$309K	Buy	3,337 +1,123	+51%	+$101K	0.07%	216
2024 Q1	$210K	Buy	+2,214	New	+$205K	0.05%	252

Other funds holding XBI

LHWM

Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return

AIC

Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

BONH

Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return

VAG

VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return

WAM

Worth Asset Management Dallas, Texas $343M AUM 29.82% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.5B AUM 13.03% 1-Year Est. Return

Breakwater Capital Group's XBI Position: Q3 2026 in Review

Breakwater Capital Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.5% in Q3 2026, buying an estimated $79.1K and bringing the position to 20,157 shares worth $3.18M. The position accounts for 0.38% of the portfolio, ranked #62.

Breakwater Capital Group first reported a position in XBI in Q1 2024 and has held it in 11 quarters since. 39 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Breakwater Capital Group held 20,157 shares of State Street SPDR S&P Biotech ETF worth $3.18M as of Q3 2026.
Breakwater Capital Group bought 501 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $79.1K.
State Street SPDR S&P Biotech ETF made up 0.38% of Breakwater Capital Group's portfolio in Q3 2026, its #62 holding.
Breakwater Capital Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 11 quarters since.
39 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Breakwater Capital Group's 13F filing for Q3 2026, filed 9 Oct 2026.